These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 18279219

  • 1. Molecular characterization of two novel VEGFR3 mutations in Japanese families with Milroy's disease.
    Futatani T, Nii E, Obata M, Ichida F, Okabe Y, Kanegane H, Miyawaki T.
    Pediatr Int; 2008 Feb; 50(1):116-8. PubMed ID: 18279219
    [No Abstract] [Full Text] [Related]

  • 2. Milroy's primary congenital lymphedema in a male infant and review of the literature.
    Kitsiou-Tzeli S, Vrettou C, Leze E, Makrythanasis P, Kanavakis E, Willems P.
    In Vivo; 2010 Feb; 24(3):309-14. PubMed ID: 20555004
    [Abstract] [Full Text] [Related]

  • 3. Identification of a novel VEGFR-3 missense mutation in a Chinese family with hereditary lymphedema type I.
    Yu Z, Wang J, Peng S, Dong B, Li Y.
    J Genet Genomics; 2007 Oct; 34(10):861-7. PubMed ID: 17945164
    [Abstract] [Full Text] [Related]

  • 4. Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3.
    Spiegel R, Ghalamkarpour A, Daniel-Spiegel E, Vikkula M, A Shalev S.
    J Hum Genet; 2006 Oct; 51(10):846-850. PubMed ID: 16924388
    [Abstract] [Full Text] [Related]

  • 5. A Milroy case with FLT4/VEGFR3 mutation and an unusual skin biopsy.
    Liu NF, Yu ZY, Lou Y, Sun D.
    Br J Dermatol; 2019 Jan; 180(1):223-224. PubMed ID: 30169892
    [No Abstract] [Full Text] [Related]

  • 6. A novel VEGFR3 mutation causes Milroy disease.
    Butler MG, Dagenais SL, Rockson SG, Glover TW.
    Am J Med Genet A; 2007 Jun 01; 143A(11):1212-7. PubMed ID: 17458866
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Compound heterozygosity for a variably penetrant variant and a variant of unknown significance in FLT4 causes fully penetrant Milroy's lymphedema.
    Kim J, Lim SY.
    Lymphology; 2022 Jun 01; 55(2):41-46. PubMed ID: 36170577
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A NOVEL FLT4 GENE MUTATION AND MR LYMPHANGIOGRAPHY IN A CHINESE FAMILY WITH MILROY DISEASE.
    Liu NF, Yu Z, Luo Y, Sun D, Yan Z.
    Lymphology; 2015 Jun 01; 48(2):93-6. PubMed ID: 26714373
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.
    Connell FC, Ostergaard P, Carver C, Brice G, Williams N, Mansour S, Mortimer PS, Jeffery S, Lymphoedema Consortium.
    Hum Genet; 2009 Jan 01; 124(6):625-31. PubMed ID: 19002718
    [Abstract] [Full Text] [Related]

  • 15. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.
    Gordon K, Schulte D, Brice G, Simpson MA, Roukens MG, van Impel A, Connell F, Kalidas K, Jeffery S, Mortimer PS, Mansour S, Schulte-Merker S, Ostergaard P.
    Circ Res; 2013 Mar 15; 112(6):956-60. PubMed ID: 23410910
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Identification of VEGFR3 gene mutation in a Chinese family with autosomal dominant primary congenital lymphoedema].
    Sheng JQ, Zeng F, Li C, Liu JY, Wang Q, Liu MG.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug 15; 27(4):371-5. PubMed ID: 20677139
    [Abstract] [Full Text] [Related]

  • 18. Functional analysis of FLT4 mutations associated with Nonne-Milroy lymphedema.
    Verstraeten VL, Holnthoner W, van Steensel MA, Veraart JC, Bladergroen RS, Heckman CA, Keskitalo S, Frank J, Alitalo K, van Geel M, Steijlen PM.
    J Invest Dermatol; 2009 Feb 15; 129(2):509-12. PubMed ID: 18719607
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.